COVID-19 Pandemic to Propel Growth of Global Mechanical Ventilators Market
|
By HospiMedica International staff writers Posted on 27 Jul 2020 |

Illustration
The global mechanical ventilators market is set to grow at a steady rate over the next few years and witness generation of novel growth opportunities with the COVID-19 pandemic acting as the major propeller of growth.
These are the latest findings of TMR Research (San Francisco, CA, USA), a market research and consulting services firm.
As millions of people become infected globally and many needing critical care, the demand for ventilators has soared which has become a key growth driver for the market. The demand for ventilators will remain high in hospitals and other care facilities where authorities will try to stock up on life-saving equipment. Additionally, the players in the vendor landscape are likely to adopt novel growth strategies which will keep the mechanical ventilators market buoyant.
The improving healthcare infrastructure in developing economies and growing awareness about accessible medications for constant respiratory ailments has led to faster acceptance of mechanical ventilators in these nations, thereby boosting the market growth. Increasing government support, higher discretionary cashflow, and private subsidizing for counteraction and effective treatment of respiratory illnesses will act as the key growth drivers of the mechanical ventilators market. The increasing requirement for critical care for delayed sicknesses and extended treatment for lung diseases among the young and grown-up population are expected to contribute further to the growth of the global mechanical ventilators market over the coming years.
An increase in the incidence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD) is also driving a higher demand for mechanical ventilators. Additionally, the rising geriatric population is expected to further boost market growth. Strong government support, particularly in developing economies, is likely to fuel the growth of the mechanical ventilators market. Manufacturers in developing economies, such as India and China, are focusing on producing cost-proficient, minimally-invasive ventilators to cater to the growing demand. Technological advancements, such as improved weaning, better gas trade, improvement in oxygenation, and minimum harm to the lungs will also contribute further to the market growth.
Governments across the world, particularly in the developing regions, are making efforts to improve healthcare outcomes, particularly in the case of a raging pandemic. Over the next few years, North America is set to account for a large share of the global mechanical ventilators market, although Asia Pacific is set to achieve notable growth. The growth of the mechanical ventilators market in Asia Pacific will come on the back of the robust healthcare infrastructure and key manufacturers present in the region. The growth of the North American mechanical ventilators market will be led by improving infrastructure and increase in incidence of chronic illnesses in the region. Asia Pacific is projected to hold the largest share in the global mechanical ventilators market due to rising cases of coronavirus in India and other Asian countries. Since the coronavirus originated in China, the country is witnessing the highest demand for mechanical ventilators. As a result, the global mechanical ventilators market will be dominated by the Asia Pacific region over the coming years.
Related Links:
TMR Research
These are the latest findings of TMR Research (San Francisco, CA, USA), a market research and consulting services firm.
As millions of people become infected globally and many needing critical care, the demand for ventilators has soared which has become a key growth driver for the market. The demand for ventilators will remain high in hospitals and other care facilities where authorities will try to stock up on life-saving equipment. Additionally, the players in the vendor landscape are likely to adopt novel growth strategies which will keep the mechanical ventilators market buoyant.
The improving healthcare infrastructure in developing economies and growing awareness about accessible medications for constant respiratory ailments has led to faster acceptance of mechanical ventilators in these nations, thereby boosting the market growth. Increasing government support, higher discretionary cashflow, and private subsidizing for counteraction and effective treatment of respiratory illnesses will act as the key growth drivers of the mechanical ventilators market. The increasing requirement for critical care for delayed sicknesses and extended treatment for lung diseases among the young and grown-up population are expected to contribute further to the growth of the global mechanical ventilators market over the coming years.
An increase in the incidence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD) is also driving a higher demand for mechanical ventilators. Additionally, the rising geriatric population is expected to further boost market growth. Strong government support, particularly in developing economies, is likely to fuel the growth of the mechanical ventilators market. Manufacturers in developing economies, such as India and China, are focusing on producing cost-proficient, minimally-invasive ventilators to cater to the growing demand. Technological advancements, such as improved weaning, better gas trade, improvement in oxygenation, and minimum harm to the lungs will also contribute further to the market growth.
Governments across the world, particularly in the developing regions, are making efforts to improve healthcare outcomes, particularly in the case of a raging pandemic. Over the next few years, North America is set to account for a large share of the global mechanical ventilators market, although Asia Pacific is set to achieve notable growth. The growth of the mechanical ventilators market in Asia Pacific will come on the back of the robust healthcare infrastructure and key manufacturers present in the region. The growth of the North American mechanical ventilators market will be led by improving infrastructure and increase in incidence of chronic illnesses in the region. Asia Pacific is projected to hold the largest share in the global mechanical ventilators market due to rising cases of coronavirus in India and other Asian countries. Since the coronavirus originated in China, the country is witnessing the highest demand for mechanical ventilators. As a result, the global mechanical ventilators market will be dominated by the Asia Pacific region over the coming years.
Related Links:
TMR Research
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel








